Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
IRD
Stock Latest News
Ratings
Opus Genetics: Favorable Risk‑Reward in OPGx-BEST1 Gene Therapy Underpins Buy Rating and $6 Price Target
5d ago
IRD
Premium
Ratings
Opus Genetics: Validated AAV Platform and High-Value IRD Pipeline Underpin Buy Rating and Attractive Risk‑Reward
14d ago
IRD
Premium
The Fly
Opus Genetics launches gene therapy clinical trial for retinitis pigmentosa
15d ago
IRD
Premium
The Fly
Opus Genetics initiated with a Buy at BTIG
22d ago
IRD
Premium
Company Announcements
Opus Genetics Highlights Gene Therapy Strategy at JPM Conference
30d ago
8K
IRD
Premium
Company Announcements
Opus Genetics Details 2025 Progress and 2026 Milestones
1M ago
8K
IRD
Premium
The Fly
Opus Genetics highlights 2025 progress, upcoming 2026 catalysts
1M ago
IRD
Premium
Company Announcements
Opus Genetics Partner Files Supplemental NDA for Presbyopia Drug
2M ago
8K
IRD
Premium
The Fly
Opus Genetics initiated with a Buy at B. Riley
2M ago
IRD
Premium
The Fly
Opus Genetics initiated with a Buy at B. Riley
2M ago
IRD
Premium
The Fly
Opus announces recommendation for IDMC for Phase 1/2 trial of OPGx-BEST1
2M ago
IRD
Premium
The Fly
Opus Genetics initiated with a Buy at Brookline
2M ago
IRD
Premium
The Fly
Opus Genetics initiated with an Overweight at Piper Sandler
3M ago
IRD
Premium
Market News
Buy These 3 Penny Stocks Now, Say Five-Star Analysts
3M ago
DC
IRD
Premium
The Fly
Opus Genetics doses first participant in OPGx-BEST1 Phase 1/2 trial
3M ago
IRD
Premium
Ratings
Promising Advancements in Opus Genetics’ Retinal Disease Platform Support Buy Rating
3M ago
IRD
Premium
Ratings
Opus Genetics: Buy Rating Backed by Strong Financials, Regulatory Support, and Promising Study Progress
3M ago
IRD
Premium
The Fly
Opus Genetics reports Q3 EPS (25c) vs (29c) last year
3M ago
IRD
Premium
Company Announcements
Opus Genetics Announces $23M Direct Offering
3M ago
8K
IRD
Premium
Ratings
Positive Outlook for Opus Genetics: Regulatory Support and Financial Stability Justify Buy Rating
3M ago
IRD
Premium
Company Announcements
Opus Genetics Announces $23 Million Direct Offering
3M ago
8K
IRD
Premium
The Fly
Opus Genetics announces $23M registered direct offering
3M ago
IRD
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
